Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
56
Participants
Timeline
Start Date
October 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
Conditions
Exposure
Interventions
DRUG
SP-333
Trial Locations (1)
92801
Anaheim Clinical Trials, Anaheim
All Listed Sponsors
lead
Bausch Health Americas, Inc.
INDUSTRY
NCT01705938 - Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter